Using Serious Games to Improve Social Skills in Autism (SAGA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03690661 |
Recruitment Status :
Recruiting
First Posted : October 1, 2018
Last Update Posted : July 7, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Autism Spectrum Disorder Autism | Behavioral: Intervention Video Game Behavioral: Placebo Control Game | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Masking Description: | Double blinded |
Primary Purpose: | Basic Science |
Official Title: | Using Serious Games to Improve Social Skills in Autism |
Actual Study Start Date : | December 1, 2019 |
Estimated Primary Completion Date : | July 31, 2023 |
Estimated Study Completion Date : | July 31, 2023 |

Arm | Intervention/treatment |
---|---|
Experimental: Intervention Video Game
Participants will play the Intervention Video Game for 3 months, 3 times a week for a minimum of 30 minutes each session
|
Behavioral: Intervention Video Game
The intervention game employs evidence-based "serious game" mechanics (e.g., storylines, long-term goals, scaling difficulty) to design a learning environment that maximizes opportunities for adolescents with ASD to discover the functional utility of eye gaze cues. |
Placebo Comparator: Control Video Game
Participants will play the Control Video Game for 3 months, 3 times a week for a minimum of 30 minutes each session
|
Behavioral: Placebo Control Game
The placebo game will have all the elements of the serious game mechanics of the intervention game (narrative storylines, long-term goals, scaling difficulty), but will not provide the learning opportunities regarding eye gaze cues. |
- Primary Target Eye Gaze Mechanisms - Performance Accuracy [ Time Frame: 6 months ]Performance accuracy will be acquired from both a static and a dynamic task of eye gaze cue following, which will be analyzed separately (ie 6 months from pre-intervention).
- Primary Target Eye Gaze Mechanisms - Visual Fixation [ Time Frame: 6 months ]Eye tracking measures of visual fixation will be acquired in both a static and a dynamic task of eye gaze cue following, which will be analyzed separately (ie 6 months from pre-intervention).
- Social Symptoms - Social Skills Inventory System (SSIS) [ Time Frame: 6 months ]Social skills and problematic behaviors will be assessed via parent- and self-reported responses on the SSIS. These measures will be administered at multiple time points including pre-intervention, post-intervention, and 3 months after the intervention (ie 6 months from pre-intervention).
- Autism Behaviors - Social Responsiveness Scale 2nd Edition (SRS-2) [ Time Frame: 6 months ]To assess potential changes in autism-like behaviors and symptoms, parents will complete the SRS-2 at each of 3 time points (pre-intervention, post-intervention, 3-month follow-up after intervention completion).
- Intermediate Face Processing Mechanisms - Face Identity (CFMT) [ Time Frame: 6 months ]Accuracy in face recognition will be assessed via standardized measures including Cambridge face memory task (CFMT) at each time point including pre-intervention, post-intervention, and 3 months after the intervention (ie 6 months from pre-intervention).
- Intermediate Face Processing Mechanisms - Object Identity (CBMT) [ Time Frame: 6 months ]Accuracy in object recognition will be assessed via standardized measures including Cambridge bike memory task (CBMT) at each time point including pre-intervention, post-intervention, and 3 months after the intervention (ie 6 months from pre-intervention).
- Intermediate Face Processing Mechanisms - Face Expression Identification - (CAM) [ Time Frame: 6 months ]Accuracy in face expression identification will be assessed via standardized measures including the face portion of the Cambridge Affective Memory task (CAM) at each time point including pre-intervention, post-intervention, and 3 months after the intervention (ie 6 months from pre-intervention).
- Intermediate Face Processing Mechanisms - Face Expression Identification - (RMET) [ Time Frame: 6 months ]Accuracy in face expression identification will be assessed via standardized measures including the face portion of the Reading the Mind in the Eyes Test (RMET) at each time point including pre-intervention, post-intervention, and 3 months after the intervention (ie 6 months from pre-intervention).
- Face-to-Face Social Interactions - Visual Fixations [ Time Frame: 6 months ]Eye tracking measures (ie visual fixations) will be collected during a naturalistic social conversation. Additionally, eye tracking measures will be collected during an interactive cued eye gaze task, which requires participants to select the object that a real person is looking at. These measures will be assessed at multiple time points including pre-intervention, post-intervention, and 3 months after the intervention (ie 6 months from pre-intervention).

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 10 Years to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- parent/caregiver of an adolescent with a diagnosis of autism spectrum disorder (ASD),
- parent/caregiver and adolescent with ASD both native English speakers,
- adolescent with ASD aged between 10-18 years at pre-test,
- adolescent has normal vision and hearing with correction as reported by caregiver,
- adolescent is able to use a computer for the purposes of game play,
- adolescent scores < 80% correct (i.e., 0.5 SD less than Mean of typically developing adolescents) on online eye gaze screening task,
- ASD diagnosis of adolescent confirmed via Parent-report SCQ and clinical interview with adolescent to assess DSM-V criteria (borderline cases also undergo ADI interview);
- Full Scale IQ of adolescent determined to be between 70-130;
- reading ability of adolescent determined to be at least a 2nd grade level;
- adolescent is capable of cooperating with testing;
- parent/caregiver and adolescent both consent/assent to participate in the research.
Exclusion Criteria:
- having seizures within the previous two years
- no stable internet connection in the home
- refusing to consent/assent to take part in the research
- 18 and have a legal guardian, which prohibits them from legally consenting for themselves
- 18 and cannot understand the consent as indicated by failing a quiz prior to signing the consent.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03690661
Contact: Suzy Scherf | 814-867-2921 | suzyscherf@psu.edu |
United States, Pennsylvania | |
Pennsylvania State University | Recruiting |
University Park, Pennsylvania, United States, 16802 | |
Contact: Suzy S Scherf 814-867-2921 suzyscherf@psu.edu | |
Principal Investigator: Suzy Scherf, PhD |
Principal Investigator: | Suzy Scherf | Penn State University |
Responsible Party: | K. Suzanne Scherf, Associate Professor of Psychology, Penn State University |
ClinicalTrials.gov Identifier: | NCT03690661 |
Other Study ID Numbers: |
R33MH110624 ( U.S. NIH Grant/Contract ) R33MH110624 ( U.S. NIH Grant/Contract ) |
First Posted: | October 1, 2018 Key Record Dates |
Last Update Posted: | July 7, 2022 |
Last Verified: | July 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | Participants will be invited to share de-identified data acquired from this study with the National Institutes of Health Data Archive |
Supporting Materials: |
Study Protocol Informed Consent Form (ICF) |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
adolescent face social skills video game |
Autistic Disorder Autism Spectrum Disorder Child Development Disorders, Pervasive Neurodevelopmental Disorders Mental Disorders |